Bayer's novel drug for stroke recurrence wins FDA approval Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.

Bayer's novel drug for stroke recurrence wins FDA approval Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding. Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.